Oxaliplatin
Active substance: oxaliplatin
INJECTION, SOLUTION · OXALIPLATIN 5 mg/mL
United StatesActive
Marketing holder: Baxter Healthcare Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- OXALIPLATIN · 5 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 47 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4ff5-72c8-b2f0-afb6bcc42bc7,01a1208c-5b40-7d63-aeae-de8f84c4ab1b,01a1208c-5c21-7ebb-963d-9de38134dd96,01a1208c-a513-7bca-abd4-6704c15a2316,01a1208d-03c3-7361-a9a8-85ba03a719b2;count=40 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43066-014
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 43066-014 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43066-014 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43066-014 · Verified 2026-10-09 · open in source